CDX logo

CDX ETF

Profile

Name:

Simplify High Yield PLUS Credit Hedge ETF

Assets under management:

$123 M

Expense ratio:

0.50%

Inception date:

14 February 2022

Last ex-dividend date:

28 October 2024

Next ex-dividend date:

N/A

Description:

The CDX ETF is an exchange-traded fund that tracks the performance of credit default swaps, providing investors exposure to credit risk in various sectors. It aims to offer diversification and liquidity, making it a useful tool for managing credit exposure in investment portfolios.
Name
Weight
HYGFFSTRS(HYGFFSTRS)
11.82 %
HYGFFSTRS 00001(HYGFFSTRS 00001)
11.70 %
B 01/14/25 Govt(B 01/14/25 Govt)
8.04 %
HYGNOMTRS(HYGNOMTRS)
7.73 %
HYGNOMTRS 00001(HYGNOMTRS 00001)
7.65 %
B 12/17/24 Govt(B 12/17/24 Govt)
5.94 %
MSSIQUA1A(MSSIQUA1A)
5.85 %
MSSIQUA1A 00001(MSSIQUA1A 00001)
5.60 %
MSSIJNK1A 00001(MSSIJNK1A 00001)
5.00 %
SPX TRS 01/17/25 FF+127 NOM(SPX TRS 01/17/25 FF+127 NOM)
4.82 %

Holding types

Countries

Sectors

Analyst ratings

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series
CDX: High Yield Fund With A Wide Mandate (Rating Downgrade)
CDX: High Yield Fund With A Wide Mandate (Rating Downgrade)
CDX: High Yield Fund With A Wide Mandate (Rating Downgrade)
CDX
seekingalpha.com03 December 2024

CDX has changed from a high yield ETF with a built-in hedge to a multi-asset fund. This new setup brings more risk, which means it is not a good choice for high yield portfolios. Additionally, current high yield credit spreads are at their lowest in ten years, making the overall market conditions poor for high yield investments.

Celldex Announces First Patient Dosed in Phase 1 Healthy Volunteer Study of CDX-622, a Bispecific Antibody, for the Treatment of Inflammatory Diseases
Celldex Announces First Patient Dosed in Phase 1 Healthy Volunteer Study of CDX-622, a Bispecific Antibody, for the Treatment of Inflammatory Diseases
Celldex Announces First Patient Dosed in Phase 1 Healthy Volunteer Study of CDX-622, a Bispecific Antibody, for the Treatment of Inflammatory Diseases
CDX
globenewswire.com20 November 2024

HAMPTON, N.J., Nov. 20, 2024 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) has announced that they have given the first dose of CDX-622 to a patient in their Phase 1a study involving healthy volunteers. CDX-622 is a bispecific antibody designed to target two key pathways that contribute to chronic inflammation, effectively neutralizing the alarmin thymic stromal lymphopoietin (TSLP) and reducing mast cells by depriving them of stem cell factor (SCF).

CDX: Good Way To Own High Yield Bonds
CDX: Good Way To Own High Yield Bonds
CDX: Good Way To Own High Yield Bonds
CDX
seekingalpha.com09 November 2024

The Simplify High Yield PLUS Credit Hedge ETF uses a mix of high-quality and low-quality stocks to protect against credit risk, providing a positive carry credit hedge. Although CDX helps with credit risk, it doesn't protect against rising interest rates, which can be a problem when rates go up. I recommend buying CDX because it can make high-yield bonds more attractive by reducing the risks during a downturn in credit.

Hemogenyx Pharmaceuticals hails potential of new CDX antibody
Hemogenyx Pharmaceuticals hails potential of new CDX antibody
Hemogenyx Pharmaceuticals hails potential of new CDX antibody
CDX
proactiveinvestors.co.uk02 September 2024

Hemogenyx Pharmaceuticals PLC (LSE:HEMO, OTC:HOPHF) has announced the development of a new version of its bi-specific CDX antibody aimed at treating relapsed or refractory acute myeloid leukaemia (AML), which also shows potential for use in bone marrow transplant conditioning. The improved CDX, developed using Lonza's bYlok bispecific pairing technology, has demonstrated significantly enhanced efficacy in laboratory testing, with further animal studies currently in progress.

Credit Hedging Done Right: CDX Outperforms With Defense
Credit Hedging Done Right: CDX Outperforms With Defense
Credit Hedging Done Right: CDX Outperforms With Defense
CDX
seekingalpha.com23 August 2024

The credit risk in high yield bonds tends to have more volatility and credit spreads can widen swiftly during periods of market stress, wiping out income quickly. CDX deploys credit hedging techniques to mitigate credit risk. CDX has the ability to deploy credit hedges with a direct tie to credit markets, like CDS, CDX and CDX options.

CDX: If You Want To Buy High Yield Here, Buy It Hedged
CDX: If You Want To Buy High Yield Here, Buy It Hedged
CDX: If You Want To Buy High Yield Here, Buy It Hedged
CDX
seekingalpha.com25 June 2024

CDX outperformed competitors HYG and JNK in the past year from a total return perspective, and with a better drawdown profile. CDX utilizes put spreads on the S&P 500 to hedge downside moves, providing insurance against market losses. The fund offers a lower drawdown in a market sell-off due to its embedded hedge profile and put spreads, making it a smart choice for investors.

Cloud DX Inc. Announces Restructuring Process and the Resignation of 2 Directors
Cloud DX Inc. Announces Restructuring Process and the Resignation of 2 Directors
Cloud DX Inc. Announces Restructuring Process and the Resignation of 2 Directors
CDX
accesswire.com06 June 2024

KITCHENER, ON / ACCESSWIRE / June 6, 2024 / Cloud DX Inc. ("Cloud DX") (TSXV:CDX)(OTCQB:CDXFF) today reports that its wholly-owned subsidiary, Cloud Diagnostics Canada ULC (the "Company"), with the authorization and approval of its board of directors (the "Board"), has filed a Notice of Intention to Make a Proposal ("NOI") pursuant to the provisions of the Bankruptcy and Insolvency Act (Canada). Cloud Diagnostics Canada ULC is a material subsidiary of Cloud DX Inc, accounting for most of the Company's revenues.

CDX: Hedged U.S. High Yield Exposure
CDX: Hedged U.S. High Yield Exposure
CDX: Hedged U.S. High Yield Exposure
CDX
Seeking Alpha15 May 2023

The Simplify High Yield PLUS Credit Hedge ETF is a fixed-income exchange-traded fund. The vehicle focuses on U.S. high yield credit and tries to hedge the downside via SPY puts, CDX index calls, or other instruments.

FAQ

  • What is CDX ETF?
  • Does CDX pay dividends?
  • What stocks are in CDX ETF?
  • What is the current assets under management for CDX?
  • What is CDX average volume?
  • What is CDX expense ratio?
  • What is CDX inception date?

What is CDX ETF?

The CDX ETF is an exchange-traded fund that tracks the performance of credit default swaps, providing investors exposure to credit risk in various sectors. It aims to offer diversification and liquidity, making it a useful tool for managing credit exposure in investment portfolios.

Does CDX pay dividends?

Yes, the Simplify High Yield PLUS Credit Hedge ETF does pays dividends, with the most recent payment being $0.20 per share. The last ex-dividend date was on 28 October 2024, and the next ex-dividend date has not been announced yet

What stocks are in CDX ETF?

As of today, Simplify High Yield PLUS Credit Hedge ETF inlcudes 222 holdings, with 204 of them being companies from 7 different countries and 11 sectors. The most weighted holdings are HYGFFSTRS (11.82%), HYGFFSTRS 00001 (11.7%) and B 01/14/25 Govt (8.04%)

What is the current assets under management for CDX?

Assets under management of Simplify High Yield PLUS Credit Hedge ETF is $123 M

What is CDX average volume?

Average volume of Simplify High Yield PLUS Credit Hedge ETF is $39 K

What is CDX expense ratio?

Expense ratio of Simplify High Yield PLUS Credit Hedge ETF is 0.50%

What is CDX inception date?

Inception date of Simplify High Yield PLUS Credit Hedge ETF is 14 February 2022